OFFRE D'UNE DURÉE LIMITÉE | Obtenez 3 mois à 0.99 $ par mois

14.95 $/mois par la suite. Des conditions s'appliquent.
Page de couverture de Oncology Today with Dr Neil Love

Oncology Today with Dr Neil Love

Oncology Today with Dr Neil Love

Auteur(s): Dr. Neil Love
Écouter gratuitement

À propos de cet audio

 Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.Copyright 2025 Research To Practice. All Rights Reserved Hygiène et mode de vie sain Science Troubles et maladies
Épisodes
  • Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review

    Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
    Jan 21 2026

    Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.

    CME information and select publications here.
    Voir plus Voir moins
    1 h et 1 min
  • Relapsed/Refractory Multiple Myeloma — ASH 2025 Review

    Relapsed/Refractory Multiple Myeloma — ASH 2025 Review
    Jan 16 2026

    Dr Sagar Lonial from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr María-Victoria Mateos from the University Hospital of Salamanca in Salamanca, Spain, discuss cases of relapsed/refractory multiple myeloma and recentresearch findings from the 2025 ASH Annual Meeting.

    CME information and select publications here.
    Voir plus Voir moins
    1 h et 1 min
  • HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

    HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
    Jan 14 2026

    Prof Giuseppe Curigliano from the University of Milan in Italy, Prof Nadia Harbeck from LMU University Hospital in Munich, Germany, Dr Ian E Krop from Yale Cancer Center, Dr Nancy U Lin from Dana-Farber Cancer Institute and Dr Joyce O’Shaughnessy from Baylor University Medical Center discuss real-world cases and recent clinical data pertinent to the management of HER2-positive breast cancer.

    CME information and select publications here.

    Voir plus Voir moins
    1 h et 58 min
Pas encore de commentaire